{"id":"https://openalex.org/W2181764243","doi":null,"title":"For peer review only Progression -free survival is associated with a better health - related quality of life in lung cancer patients: Evidence from two randomized trials with afatinib","display_name":"For peer review only Progression -free survival is associated with a better health - related quality of life in lung cancer patients: Evidence from two randomized trials with afatinib","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2181764243","mag":"2181764243"},"language":"en","primary_location":{"id":"mag:2181764243","doi":null,"is_oa":false,"landing_page_url":"http://bmjopen.bmj.com/content/4/10/e005762.draft-revisions.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042210414","display_name":"Peter M. Fayers","orcid":"https://orcid.org/0000-0003-4778-1513","observed_orcids":["https://orcid.org/0000-0003-4778-1513"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Peter Fayers","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4778-1513","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5042210414"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10178","display_name":"Cancer survivorship and care","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8920000195503235},{"id":"https://openalex.org/keywords/health-related-quality-of-life","display_name":"health-related quality of life","score":0.9990000128746033},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.9819999933242798},{"id":"https://openalex.org/keywords/afatinib","display_name":"afatinib","score":0.9850000143051147},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.7839999794960022}],"concepts":[{"id":"https://openalex.org/C2780586478","wikidata":"https://www.wikidata.org/wiki/Q4688818","display_name":"Afatinib","level":5,"score":0.7567592263221741},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.698388934135437},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.654006838798523},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.6374439001083374},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5576719045639038},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5183268785476685},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.37778276205062866},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.36405104398727417},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30221331119537354},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.11643287539482117},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.08433327078819275},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2181764243","doi":null,"is_oa":false,"landing_page_url":"http://bmjopen.bmj.com/content/4/10/e005762.draft-revisions.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W1488694215","https://openalex.org/W1497402064","https://openalex.org/W1947168884","https://openalex.org/W1994222210","https://openalex.org/W2018304470","https://openalex.org/W2019607817","https://openalex.org/W2042450112","https://openalex.org/W2056591512","https://openalex.org/W2068811106","https://openalex.org/W2071539936","https://openalex.org/W2074146123","https://openalex.org/W2076272659","https://openalex.org/W2085518532","https://openalex.org/W2096198395","https://openalex.org/W2098428600","https://openalex.org/W2102350520","https://openalex.org/W2138922782","https://openalex.org/W2139248078","https://openalex.org/W2143632656","https://openalex.org/W2145816995","https://openalex.org/W2150747041","https://openalex.org/W2152905269","https://openalex.org/W2167571044","https://openalex.org/W2473786944"],"related_works":["https://openalex.org/W7096165741","https://openalex.org/W2140692450","https://openalex.org/W2311843605","https://openalex.org/W2937559933","https://openalex.org/W2026951964","https://openalex.org/W2581008517","https://openalex.org/W7096776009","https://openalex.org/W2466556270","https://openalex.org/W2658185239","https://openalex.org/W2325967563"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}